Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Compounded semaglutide: a different situation entirely Compounded semaglutide operates under fundamentally different rules
Semaglutide is a weight loss drug that targets the glucagon-like peptide-1 (GLP-1), sold by Novo Nordisk under the brand name Wegovy to treat people with obesity and under Ozempic to treat patients with both type 2 diabetes and obesity
Low adherence to GLP-1 drugs could limit long-term mortality benefits
The covariates included age (modelled as a continuous variable using cubic splines with five knots at the 5th, 27.5th, 50th, 72.5th, and 95th centiles), sex, smoking status, body mass index, alcohol related disorders, and cohort entry year (2013-15, 2016-18, 2019-21)
US$ 23.53
US$ 20.81
US$ 24.22
US$ 27.42
US$ 27.03
US$ 21.46
